DG 35
Alternative Names: NSC 654021Latest Information Update: 06 Aug 1998
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 06 Aug 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 08 Feb 1996 New profile
- 08 Feb 1996 Preclinical development for HIV infections treatment in USA (Unknown route)